Biomedical Chemistry and Applications (ICBCA-27)

This track focuses on the latest research and innovations in medicinal chemistry, emphasizing novel drug design and development strategies. Participants will explore the integration of chemical biology and pharmacology in creating effective therapeutic agents.

This session highlights cutting-edge technologies and methodologies in biomedical engineering that enhance healthcare delivery. Topics include the development of medical devices, imaging techniques, and biomaterials.

Explore the application of fluorometric analysis in biomedical chemistry for detecting and quantifying biological molecules. This track will cover advancements in fluorescence-based assays and their implications for diagnostics.

This track examines the intersection of chemical biology and drug discovery, focusing on mechanism-based approaches to identify new therapeutic targets. Discussions will include the role of small molecules in modulating biological pathways.

This session will delve into innovative strategies for targeted drug delivery, including the use of magnetic nanoparticles and other advanced carriers. Emphasis will be placed on enhancing the efficacy and reducing side effects of therapeutic agents.

Participants will discuss the design and synthesis of new antitumor and antiviral agents, highlighting recent breakthroughs in therapeutic efficacy. This track aims to foster collaboration between chemists and clinicians in the fight against cancer and viral infections.

This session focuses on the development and application of antisense and antigene agents in biomedical chemistry. Discussions will include their mechanisms of action and potential therapeutic applications in genetic disorders.

This track will cover current trends and future directions in biomedical chemistry, including interdisciplinary approaches and novel methodologies. Participants will engage in discussions on the implications of these trends for health and medicine.

Explore the role of nanotechnology in enhancing biomedical applications, including drug delivery, imaging, and diagnostics. This session will highlight the potential of nanoscale materials to revolutionize healthcare.

This track addresses the regulatory landscape impacting pharmaceutical chemistry and drug development. Participants will discuss the challenges and opportunities in navigating regulatory requirements for new therapies.

This session emphasizes integrative approaches that combine chemistry, engineering, and life sciences to address complex health challenges. Participants will explore collaborative strategies that enhance the understanding and treatment of diseases.